Recently developed mouse models with a leptin receptor mutation develop type 2 diabetes, hypertension, obesity and on the db/db or BTBR ob/ob background develop proteinuria, reduced glomerular filtration, mesangial matrix expansion and podocyte loss [73], thereby recapitulating nephropathy in type 2 diabetes. This evidence concerns the gene LEPR and type 2 diabetes mellitus.